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We hypothesized that vitamin E (α-tocopherol) is required by the developing embryonic brain to prevent
depletion of highly polyunsaturated fatty acids, especially docosahexaenoic acid (DHA, 22:6), the loss of
which we predicted would underlie abnormal morphological and behavioral outcomes. Therefore, we fed
adult 5D zebraﬁsh (Danio rerio) deﬁned diets without (E) or with added α-tocopherol (Eþ , 500 mg
RRR-α-tocopheryl acetate/kg diet) for a minimum of 80 days, and then spawned them to obtain E and
Eþ embryos. The E compared with Eþ embryos were 82% less responsive (po0.01) to a light/dark
stimulus at 96 h post-fertilization (hpf), demonstrating impaired locomotor behavior, even in the ab-
sence of gross morphological defects. Evaluation of phospholipid (PL) and lysophospholipid (lyso-PL)
composition using untargeted lipidomics in E compared with Eþ embryos at 24, 48, 72, and 120 hpf
showed that four PLs and three lyso-PLs containing docosahexaenoic acid (DHA), including lysopho-
sphatidylcholine (LPC 22:6, required for transport of DHA into the brain, po0.001), were at lower
concentrations in E at all time-points. Additionally, H218O labeling experiments revealed enhanced
turnover of LPC 22:6 (po0.001) and three other DHA-containing PLs in the E compared with the Eþ
embryos, suggesting that increased membrane remodeling is a result of PL depletion. Together, these
data indicate that α-tocopherol deﬁciency in the zebraﬁsh embryo causes the speciﬁc depletion and
increased turnover of DHA-containing PL and lyso-PLs, which may compromise DHA delivery to the brain
and thereby contribute to the functional impairments observed in E embryos.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).B.V. This is an open access article u
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.G. Traber).1. Introduction
The zebraﬁsh model presents a highly useful and translational
experimental system for investigating the impact of α-tocopherol
status on neurodevelopment, as zebraﬁsh and humans have si-
milar dietary antioxidant requirements [1]. α-Tocopherol’s re-
quirement during development may be due primarily to its fun-
damental role in facilitating healthy brain formation because
knockdown of the α-tocopherol transfer protein in zebraﬁsh em-
bryos causes lethal head and/or brain malformations [2]. Further,
we have observed that α-tocopherol deﬁcient (E) zebraﬁsh
embryos, when compared to α-tocopherol sufﬁcient (Eþ) em-
bryos, begin to develop morphologic abnormalities at 48 hoursnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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48–72 hpf with simultaneous increases in E- embryo mortality.
We propose that that the physiological link between brain health
and adequate α-tocopherol relates to the vitamin’s role as the body’s
most potent lipophilic antioxidant [4], whereby it protects highly
unsaturated membrane lipids that are vulnerable to peroxidation [5].
Foremost among these in terms of susceptibility to peroxidation is
docosahexaenoic acid (DHA; 22:6) [6], a long-chain ω-3 poly-un-
saturated fatty acid (PUFA) that is highly concentrated in nervous
tissue [7] and is critical for neurodevelopment [8,9], as well as for
preservation of lifetime neurological function [10,11]. Given that the
developing brain consumes 60% of fetal oxygen [12], this environment
makes adequate antioxidant status especially crucial for protection of
vital membrane lipids like DHA.
We recently demonstrated that α-tocopherol deﬁciency sig-
niﬁcantly altered the PL composition of the brain in adult E
zebraﬁsh by causing the speciﬁc depletion of PL species containing
DHA [13]. Intriguingly, we also found that α-tocopherol deﬁciency
disrupts brain lysophospholipid (lyso-PL) status, resulting in an
overall depletion of lipid species by approximately 60% [13]. Lyso-
PLs are substrates for the synthesis, remodeling, and repair of
membrane PLs [14,15]; thus, the results from our adult studies
suggest these processes are compromised in the E brain. One
depleted lyso-PL species in particular, lysophosphatidylcholine
(LPC) 22:6, also is essential for normal DHA delivery to the brain
[16,17], where evidence shows that DHA is required for function
and maintenance of neural membranes, such as the blood-brain
barrier [18,19]. In addition, inadequate brain DHA has been found
to compromise membrane integrity within the developing zebra-
ﬁsh [20], leading to brain deformities and early mortality.
In light of our lipidomics data from adult E zebraﬁsh brains
[13] as well as our past studies showing morphological defects
that coincide with the rapid depletion of DHA during development
in E embryos [3,21], we hypothesized that embryonic α-toco-
pherol deﬁciency compromises brain development by decreasing
the supply of DHA to the embryonic brain, which perturbs DHA-
containing PL and lyso-PL (speciﬁcally, LPC 22:6) status and, hence,
processes of membrane PL remodeling. Further, given the nu-
merous reports of adverse behavioral outcomes due to embryonic
DHA deﬁciency, we also postulated that the disruption of mem-
brane DHA content may correlate with the onset of behavioral
abnormalities in the developing embryonic zebraﬁsh. Herein, we
exploited our high-throughput embryonic assessments and lipi-
domics techniques, as well as developed a method to measure PL
turnover in zebraﬁsh embryos using H218O labeling, to gain me-
chanistic insight on the organism-level effects of developmental
α-tocopherol deﬁciency.2. Materials and methods
2.1. Materials
1,2-ditridecanoyl-sn-glycero-3-phosphocholine (DT-PC) was
obtained from Avanti Polar Lipids Inc. (Alabaster, AL) and used
without further puriﬁcation. H218O (18O, 97%) was obtained from
Cambridge Isotope Laboratories (Tewksbury, MA). Butylated hy-
droxytoluene (BHT) was obtained from TCI America (Portland, OR).
2.2. Zebraﬁsh husbandry and diets
The Institutional Animal Care and Use Committee (IACUC) of
Oregon State University approved this protocol (ACUP Number:
4344). Tropical 5D strain zebraﬁsh were housed in the Sinnhuber
Aquatic Research Laboratory. Adults were kept at standard la-
boratory conditions of 28 °C on a 14-h light/10-h dark photoperiodin ﬁsh water (FW) consisting of reverse osmosis water supple-
mented with a commercially available salt (Instant Oceans) to
create a salinity of 600 microsiemens. Sodium bicarbonate was
added as needed to adjust the pH to 7.4.
At 55 days post-fertilization (dpf), zebraﬁsh were randomly
allocated to one of two diet groups, α-tocopherol deﬁcient (E) or
α-tocopherol sufﬁcient (Eþ), and fed one of the deﬁned diets for
the duration of the study [22]. The deﬁned diets, which contained
only fatty acids with 18 or fewer carbons and 2 or 3 double bonds
[3,22], were prepared with the vitamin C source as StayC (500 mg/
kg, Argent Chemical Laboratories Inc., Redmond, WA) and without
(E) or with added α-tocopherol (Eþ , 500 mg RRR-α-tocopheryl
acetate/kg diet, ADM, Decatur, IL), as described previously [21,22].
Diets were stored at 20 °C until fed to the adult zebraﬁsh.
E and Eþ embryos were obtained from adult ﬁsh fed either the
E or Eþ diet, respectively, for a minimum of 80 days. Embryos
were obtained through natural group spawning, collected, and kept
in standard embryo media (EM; prepared as described [1] from
0.137 M NaCl, 5.4 mM KCl, 0.25 mM Na2HPO4, 0.44 mM KH2PO4,
1.3 mM CaCl2, 1.0 mM MgSO4 and 4.2 mM NaHCO3; pH 7.2–7.4).
Embryos used for biochemical analysis, described below, were eu-
thanized by cold exposure (placed on ice of a minimum of 30 min)
prior to sampling. Note that embryos are not fed prior to 120 hours
post fertilization (hpf), as each is a complete unit containing only
those nutrients present in the yolk when eggs are laid, which the
embryo fully utilizes by 120 hpf. For the experiments described
herein, the Eþ embryos are considered the control condition.
2.3. Vitamin E analyses
Using high pressure liquid chromatography with electrochemical
detection (HPLC-ECD), α-tocopherol was measured both in diet sam-
ples and embryos, as described [23]; ascorbic acid content in diet was
measured using HPLC-ECD as described [24]. Measured α-tocopherol
concentrations in the E and Eþ diets were 0.4570.01 and
36972mg/kg (n¼3 replicate samples measured for each diet), re-
spectively; vitamin C was 143716mg ascorbic acid/kg. This level of
dietary vitamin C has been found to be adequate for the zebraﬁsh
[25,26]. Measured α-tocopherol concentrations in the E and Eþ
embryos at 24 hpf were 3.470.1 and 10573 pmol/embryo, respec-
tively, similar to previous reports [3,21].
2.4. Evaluation of phenotypic and developmental progress
At 24 hpf, embryos were assessed for viability, developmental
progression and spontaneous movements (earliest behavior in
zebraﬁsh), using the zebraﬁsh acquisition and analysis program
(ZAAP). ZAAP is a custom program designed to inventory, acquire,
and manage zebraﬁsh data, and was used to collect 18 develop-
mental endpoints, as either present or absent (i.e. binary responses
were recorded, described below) [27]. Developmental progression
is considered perturbed if zebraﬁsh are more than 12 h delayed
compared to control animals. Spontaneous movements are as-
sessed over a 2 min. period and are considered perturbed if there
is a lack of embryonic contractions and/or movement. At 96 hpf,
larval morphology (body axis, eye, snout, jaw, otic vesicle, no-
tochord, heart, brain, somite, ﬁn, yolk sac, trunk, circulation, pig-
ment, and swim bladder) was evaluated and recorded and beha-
vioral endpoints (motility, tactile response) were thoroughly
evaluated in vivo. If the embryo was dead at either 24 or by 96 hpf,
the non-mortality endpoints were not included in the evaluations.
2.5. Behavioral assessments
Locomotor activity was measured using Viewpoint Zebrabox
[28,29] in a total of n¼128 embryos per diet group. Brieﬂy, at 96 hpf,
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ZebraBox (software version 3.0, Viewpoint Life Sciences, Lyon,
France). Embryo locomotor activity was assessed using the
“tracking” setting during alternating periods of light and dark, a
modiﬁcation of Ref. [30]. Embryos subjected to this test typically
move less during the light periods and more during dark periods,
and behavioral differences can be determined by comparing dis-
tances moved during the light and/or dark periods. Locomotor
activity in response to the light/dark transition was tracked during
3 min. periods of alternating light and dark for a total of 24 min.
The integration time was set to 6 s to increase statistical power. A
high deﬁnition camera (30 frames/s) tracked the total movement
(swim distance) in response to the multiple light-dark transitions.
2.6. Zebraﬁsh embryo lipidomics analyses
At 12 hpf, E and Eþ embryos were transferred one embryo per
well into 96 well plates containing 100 μL EM per well. Following 24,
48, 72, and 120 hpf, embryos (15 per replicate, n¼4 replicates per
group) were transferred to 1.5 mL Eppendorf tubes, covered with EM,
and kept on ice for 30 min to euthanize the animals. EM was care-
fully removed to prevent loss of embryos and samples were stored at
80 °C overnight. To extract embryos for lipidomics analyses, sol-
vent (300 μL, 25:10:65 v/v/v methylene chloride: isopropanol: me-
thanol, with 50 μg/mL butylated hydroxytoluene [BHT]) and internal
standard (0.5 mg/mL, 1,2-ditridecanoyl-sn-glycero-3-phosphocholine
[DT-PC, PC 26:0] in methanol) was added. Next, sample extracts were
homogenized with 0.5 mm zirconium oxide beads (Next Advance,
Inc., Averill Park, NY, product #ZrOB05) using a counter-top bullet
blender for 6 min.; then, following a 15 min. incubation on ice, the
extracts were centrifuged at 4 oC at 15,000 g for 13 min. Aliquots
(200 μL) of the upper layer were transferred individually to new
tubes and stored at 80 °C until analysis.
2.7. H2
18O incorporation by embryos
To optimize H218O labeling into lipids, a cohort of laboratory
embryos (n¼180; from adult 5D zebraﬁsh not subjected to dietary
manipulation) were incubated with increasing concentrations of
H218O (0% to 50% v/v in EM) from 48 to 72 hpf (n¼15 embryos per
replicate, 2 replicates per concentration) to determine the H218O
concentration that yielded the greatest label incorporation. In-
cubation for 24 h (48–72 hpf) with a 40% v/v concentration of
H218O provided optimal labeling of PL species (Supplementary
Data). Embryos showed no signs of toxicity when assessed using a
phenotypic screen (ZAAP), described above, following exposure to
any concentration of the H218O label used in the present experi-
ment. The outcome of this pilot trial informed the H218O labeling
study with E and Eþ embryos, in which a cohort of 48 hpf E
and Eþ embryos (n¼120/group) was incubated with either 40% v/
v H218O in EM (n¼60/group) or with 40% v/v reverse-osmosis
water (H2O) in EM (n¼60/group) from 48 to 72 hpf. At 72 hpf,
embryos used for the labeling study were extracted as described
above for lipidomics sample preparation.
2.8. UPLC-TOF-MS/MS analyses
Lipidomics analyses of the embryo extracts were carried out to
identify lipids, which changed as a result of the dietary manip-
ulation. Liquid chromatography/mass spectrometry (LC/MS) was
performed using a UPLC with a 1.8 mm particle 1002.1 mm2 id
HSS T3 column (Waters, Milford, MA) coupled to a hybrid quad-
rupole time-of-ﬂight mass spectrometer (UPLC-TOF-MS/MS; SCIEX
5600) operated in information dependent MS/MS acquisition
mode, as described [13]. Data were generated from the UPLC se-
paration of each lipid extract using TOF accurate mass detectionand MS/MS fragment characterization. Data was imported into
PeakView software (Version 1.2, SCIEX) for relative quantiﬁcation
and lipid identiﬁcation. Lipid species were conﬁrmed by validated
UPLC retention times, high resolution MS, MS/MS fragmentation,
and isotopic distribution using the PeakView database. Peak in-
tensities were normalized using DT-PC (internal standard) in-
tensities and then used for relative quantiﬁcation between Eþ and
E embryo samples and expressed per embryo based on the
numbers of embryos extracted.
For assessment of H218O labeling, extracts were analyzed using
the UPLC-TOF-MS/MS by following the lipidomics protocol. The
incorporation of the H218O label was determined by comparing
[MþH]þ and [Mþ2þH]þ mass spectral peak intensities from
isotopic distributions of individual lipid species. Mass spectral
peak identities were conﬁrmed as described above, using validated
UPLC retention times, high resolution MS, and MS/MS fragmen-
tation. The ratio of [Mþ2þH]þ/[MþH]þ was used as a metric to
measure the extent of H218O label incorporation (minus the ratio
found for unlabeled-H2O incubated embryos).
2.9. Statistical analyses
Heatmaps of lipidomics data were generated using Metaboanalyst
software [31]. Sample intensities were normalized against the in-
tensity of internal standard (DT-PC) and then scaled with Pareto
scaling. All lipidomics statistical analyses were performed using
GraphPad Prism 6.0 software (GraphPad, La Jolla, CA). Multiple, un-
paired student's t-tests with Sidak-Bonferroni post-test for multiple
comparisons (po0.05) were performed for datasets from each time-
point (24, 48, 72, and 120 hpf), for each individual lipid species to
identify differences between speciﬁc lipids in E vs. Eþ embryos.
Lipid species that were signiﬁcantly different for at least three of the
four time-points between the E and Eþ diet conditions were then
analyzed using two-way ANOVA comparisons (diet vs. time) with ei-
ther a Bonferroni’s or Tukey's post-test for multiple comparisons (as
recommended by the software) to determine signiﬁcant (po0.05)
differences during the developmental time-course.
For analysis of signiﬁcance of the H218O incorporation, data from
embryos incubated with the H218O label were analyzed using repeated
measures two-way ANOVA with a Tukey’s or Sidak’s post-test
(po0.05; as recommended by the software) for multiple comparisons.
Statistical analyses for morphological and behavioral endpoints
were performed using code developed in R (R Developmental Core
Team 2014 http://www.R-project.org). For morphological assess-
ments at 24 and 96 hpf, binary responses were recorded as either
absent (0) or present (1) for each of the 18 endpoints.
For statistical analyses of behavior, raw data ﬁles were processed
using custom R scripts (R Developmental Core Team 2014, http://
www.R-project.org) with methodologies based on those previously
described [32], to average the total distance traveled for each in-
tegration time-point, then the area under the curve was computed.
The overall area under the cover was compared to the control (Eþ
deﬁned diet) using a combination of percent change (30% difference
from the control) and a Kolmogorov-Smirnov test (po0.05).3. Results
3.1. Embryonic α-tocopherol deﬁciency leads to behavioral impair-
ments in E embryos
Morphological assessments in the present study were in accord
with past observations [3]. Approximately 75–88% of the E
embryo cohorts evaluated either died or developed morphological
abnormalities after hatching from the chorion, between 48 and
72 hpf. The most prevalent abnormalities noted at 72 hpf were
Fig. 1. E embryos have morphological defects and increased mortality compared
to Eþ embryos. Representative pictures from the two diet groups at 120 hours
post-fertilization (hpf). A. Uninﬂated swim bladders in elsewise morphologically
normal E embryos that survived to this stage. B. An Eþ embryo provided for
comparison. Morphological evaluations were made using the zebraﬁsh acquisition
and analysis program (ZAAP). Phenotypic differences in E embryos became evi-
dent between 48 and 72 hpf, with most mortalities occurring by 72 hpf. By 120 hpf,
75–88% of E embryos from each spawn were malformed or dead.
Fig. 2. E embryos have impaired behavior compared to Eþ embryos when as-
sessed using a locomotor response assay. Embryos were analyzed in 96-well plates,
one embryo per well with 128 embryos per diet condition. Locomotor activity
following a series of light/dark stimuli (one stimulus every 3 min for 24 min total)
was measured as movement (mm) over time (seconds); criteria for statistical sig-
niﬁcance between conditions was an area-under-curve (AUC) difference of 430%
and po0.05 (Kolmogorov-Smirnov test). At 96 hpf, E- embryos (red) were 82% less
responsive to the light than were Eþ embryos (blue) (E- AUC:459; Eþ AUC:2468;
po0.01). Dead or malformed embryos were removed prior to data analysis (ap-
parently normal embryos: n¼54 E ; n¼94 Eþ). The abnormal behavioral re-
sponse in the E embryos is indicative of underlying perturbations in neurological
processes, as there were no observed differences in swimming behavior between
E and Eþ conditions to suggest motor impairments in the former. (For inter-
pretation of the references to color in this ﬁgure legend, the reader is referred to
the web version of this article.)
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120 hpf, the majority of E embryos also demonstrated failure to
inﬂate the swim bladder (Fig. 1), even when other abnormalities
were absent. Despite this high level of morbidity and mortality in
the E condition, a sub-set of each spawn (12–25% on average)
remained morphologically normal when compared to Eþ em-
bryos at 96 hpf, and appeared to sustain no developmental ab-
normalities. Therefore, we performed behavioral assessments to
determine if these “normal” E embryos suffered from behavioral
impairments that were not evident in the phenotypic screen.
We evaluated the behavioral impact of developmental α-toco-
pherol deﬁciency with a high-throughput locomotor response
assay and a modiﬁcation of the protocol previously described [30].
Any dead or malformed embryos at 96 hpf were excluded from the
data analysis. E embryos were 82% less active in the dark phases
than were Eþ embryos (Fig. 2). Of note, the included E embryos
displayed normal motility and tactile responses during the phe-
notypic screen that were comparable to evaluations of the Eþ
condition, indicating E embryos have a functional motor system.
3.2. Untargeted lipidomics analysis shows signiﬁcant changes in li-
pid proﬁles between E and Eþ embryos
Based on our recent ﬁnding that α-tocopherol deﬁciency re-
sults in signiﬁcant changes in the phospholipid (PL) and lyso-
phospholipid (lyso-PL) composition and status of brains from E
adult zebraﬁsh [13], we hypothesized that embryonic α-tocopherol deﬁciency also would alter PL and lyso-PL levels in E
embryos. To examine alterations in lipid distribution and relative
abundances between E and Eþ embryos, we used an UPLC-TOF-
MS/MS lipidomics technique. Four PL classes were identiﬁed in
embryo extracts, including 115 individually validated PLs and lyso-
PLs. PL classes were detected in either positive (phosphati-
dylcholine [PC], phosphatidylethanolamine [PE], lysopho-
sphatidylcholine [LPC], lysophosphatidylethanolamine [LPE]) or in
negative ion modes (phosphatidylserine [PS] and lysopho-
sphatidylserine [LPS], phosphatidylinositol [PI], and lysopho-
sphatidylinositol [LPI]); PC and PE were detected in both ion
modes.
Identities of all PL and lyso-PLs were conﬁrmed using exact
mass matching and MS/MS fragmentation patterns; for example,
PE species generated the characteristic losses of 43 and 140 Da
(positive ion mode) known to be associated with the PE head
group, while PS species showed 87 and 184 Da losses (nega-
tive ion mode). Signiﬁcant changes in the PL and lyso-PL proﬁles of
E compared to Eþ embryos were evident at each developmental
time-point (Fig. 3). A global evaluation of these differences re-
vealed that, while E embryos tended to have relatively higher
levels of many PLs and lyso-PLs during early development (24–
48 hpf), levels of these same lipids were markedly lower in the E
than in the Eþ condition by 120 hpf.
3.3. Embryonic α-tocopherol deﬁciency causes the speciﬁc depletion
of phospholipid and lysophospholipid species containing DHA
moieties
We hypothesized that E embryos would contain lower levels
of DHA-containing PLs and lyso-PLs (e.g. PC 38:6), as past in-
vestigations found the overall depletion of DHA in developing E
embryos [21]. Comprehensive analyses of the time-course lipi-
domics dataset showed that, while levels of only four out of the 75
identiﬁed PLs were signiﬁcantly different between the E and Eþ
embryos at all four developmental time-points, each contained
DHA (22:6) and each was lower in the E condition by 48 hpf
(Fig. 4). Further, in-depth evaluation of differences in the lyso-PL
composition between E and Eþ embryos demonstrated similar
ﬁndings. Of the 40 identiﬁed lyso-PLs, levels of only six were
signiﬁcantly different during multiple (three out of four)
Fig. 3. E and Eþ embryos display signiﬁcantly different PL and lyso-PL composition proﬁles during development. Heatmaps of identiﬁed PL or lyso-PL are shown. Sample
intensities were normalized against an internal standard (DT-PC 13:0/13:0) and then scaled with Pareto scaling. Figures were generated using Metabolanalyst software.
Heatmap trends (high [red], low [blue]) indicate that the E embryos contain, overall, greater quantities of lyso-PL species early in development (24 hpf) when compared to
Eþ embryos, but many of these species, notably those containing DHA (22:6), are markedly depleted by 120 hpf. PL trends are highly varied; however, E embryos contain
lesser quantities of PL species with DHA (22:6). A. PC, phosphatidylcholine; B. LPC, lysophosphatidylcholine; C. PE, phosphatidylethanolamine; D. PI, phosphatidylinositol
and PS, phosphatidylserine E. LPE, lysophosphatidylethanolamine; LPI, lysophosphatidylinositol and LPS, lysophosphatidylserine.
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most signiﬁcant differences between E and Eþ conditions con-
tained DHA (22:6) (Fig. 5).
3.4. Increased H2
18O label incorporation demonstrates enhanced
membrane phospholipid remodeling in E embryos
The 18O-labeling technique measures ester hydrolysis of parent
PLs in the presence of H218O, which results in the incorporation of
18O into the carboxyl group of the resulting lyso-PL fatty acid;
upon reacylation, the 18O is incorporated into the newly formed
ester bond of the new PL [33,34], as outlined for PC (Fig. 6). The
time-dependent increase in the incorporation of the 18O label into
PL species can, therefore, be taken as a metric of acyl turnover,
and, subsequently, processes of PL remodeling and repair [35].
Thus, we divided a cohort of 48 hpf E and Eþ embryos (n¼120/
group), then incubated half with either 40% v/v H218O (n¼60/
group) or with 40% v/v H2O (n¼60/group) for 24 hours from 48 to
72 hpf. This time-frame was chosen because it coincided with the
onset of morbidity and mortality outcomes in E embryos, which
we hypothesized may be due to underlying perturbations in PL
remodeling and/or repair mechanisms. Label incorporation was
signiﬁcantly elevated in E embryos in four PC lipids speciﬁcally
containing long-chain polyunsaturated fatty-acids, particularly
DHA (22:6) (Fig. 7A and B). The concomitant increases in H218O
labeling of both LPC 16:0 and LPC 22:6 in E embryos (Fig. 7C andD), show these lyso-PCs are involved during the remodeling of PC
38:6.4. Discussion
Our discoveries regarding the effects of α-tocopherol deﬁciency
during zebraﬁsh embryonic development show that E- embryos
have such severe morphologic defects that the survivors display
altered behaviors. Moreover, increasing defect severity is accom-
panied by depletion of a relatively limited set of PLs and lyso-PLs
containing DHA, which causes increased PL remodeling.
In agreement with our past reports [3], E embryos begin to
accumulate morphological abnormalities between 48 and 72 hpf
and the majority of embryos are severely malformed or dead by
120 hpf. Most E embryos surviving to 120 hpf fail to inﬂate the
swim bladder, even when other developmental deformities are
absent (Fig. 1A). We do not at this time know if such an observa-
tion represents a defective swim bladder or merely a delay in its
inﬂation; however, both are portents of poor survival outcomes
during later stages of development.
Developmental α-tocopherol deﬁciency may compromise brain
function, as apparently “normal” E embryos are 82% less active
during dark phases than are Eþ embryos (Fig. 2), suggesting a
signiﬁcantly impaired neurobehavioral response [30,36]. The E
embryos demonstrated a normal, robust tactile (touch) response
Fig. 4. Four speciﬁc PLs containing DHA (22:6) are signiﬁcantly lower in E embryos. Lipidomic analysis of lipid extracts from E and Eþ embryo samples (n¼15/sample;
4 samples/group) taken at 24, 48, 72, and 120 hpf. Lipid species were conﬁrmed by high-resolution MS, MS/MS fragmentation, and isotopic distribution, and then compared
using the PeakView database. Peak intensities were used for relative quantiﬁcation between E and Eþ conditions. The data shown are means7SEM. Two-way ANOVA,
Bonferroni's post-test for multiple comparisons (**po0.01, ***po0.001, ****po0.0001).
Fig. 5. E embryos show enhanced depletion of many lyso-PL species during development when compared with Eþ embryos. Data were generated and analyzed as
described in Fig. 4. Notably, the lyso-PL species showing the greatest difference between the E and Eþ conditions all contained DHA (means7SEM). Two-way ANOVA,
Bonferroni's post-test for multiple comparisons (*po0.05, **po0.01, ***po0.001, ****po0.0001). LPC 16:0 and LPC 20:3 levels at 72 hpf were signiﬁcantly altered in E vs.
Eþ embryos when analyzed using unpaired t-tests and Sidak-Bonferroni post-test (po0.001, higher in E; and p¼0.0176, lower in E , respectively), as were LPI 20:4 levels
at 120 hpf (po0.0001, lower in E).
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Fig. 6. H218O incorporation into PC lipids. The CDP-choline pathway [33,34] is a representative metabolic pathway outlining reactions that allow for H218O incorporation into
PCs and/or lyso-PCs. From the top, choline kinase (CK) phosphorylates choline to phosphocholine, which is converted to cytidine-diphosphocholine (CDP-choline) by CTP:
phosphocholine cytidylyltransferase (CCT). Choline phosphotransferase (CPT) catalyzes PC synthesis. Fatty acyl chains are cleaved from the PC sn-2 position by phospholipase A2
(PLA2) to generate lyso-PC and free fatty acids. Free fatty acids are labeled (*), rapidly converted to acyl-CoA by acyl-CoA synthetase (ACS) and used for acylation of lyso-PL in
a reaction catalyzed by acylglycerolphosphate acyltransferases (AGPAT). PC may be cleaved by PLC (phospholipase C) to yield diacylglycerides (DAG) and phosphocholine.
Hydrolysis reactions in which incorporation of the 18O label may occur are shown in red, as are the indicated oxygens that may be labeled following PL remodeling.
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typic screen, indicating that the reason underlying the impaired
behavioral response is associated with compromised brain, rather
than muscle, function. It also is possible that the E embryos
suffer compromised visual acuity; however, eye morphology and
movements in the E group were apparently normal during the
phenotypic screen. Given that the E embryos did demonstrate
greater locomotor activity during the dark when compared to the
light phases, we believe that compromised visual acuity was not
the main cause of the impaired behavior observed in the E
condition. Instead, we argue that the perturbed behavior in E
embryos is primarily due to consequences of inadequate brain α-
tocopherol and the subsequent changes in the brain PL and lyso-PL
composition.
Our lipidomics data supports the hypothesis that the behavioral
abnormalities in the E group are, at least in part, a consequence of
disrupted PL and lyso-PL status during development. While sig-
niﬁcant differences between E and Eþ embryos are noticeable in
the global PL and lyso-PL pool at each developmental time-point
(Fig. 3), we found that only four PLs, all containing DHA, are sig-
niﬁcantly decreased throughout development from 24 to 120 hpf in
E when compared to Eþ embryos (Fig. 4). Two of these, PC 38:6
(also lower by 30% in adult E vs. Eþ zebraﬁsh brains [13]) and PC
40:6, are plasma biomarkers that are depleted in humans who pro-
gress to dementia [37], raising the provocative possibility that lower
levels of these PLs cause compromised neurodevelopment.Relatedly, we found that six lyso-PLs are signiﬁcantly altered in
E embryos during the developmental time-course (Fig. 5). Of
these, three contained DHA (LPC 22:6, LPE 22:6, and LPS 22:6) and
were lower in the E condition by 120 hpf, despite being higher
in E embryos at 24 hpf. Moreover, while levels of the DHA-
containing lyso-PLs increased during development in Eþ embryos,
all decreased (rather substantially in the cases of LPC 22:6 and LPE
22:6) in E embryos, suggesting developmental α-tocopherol
deﬁciency leads to the rapid depletion of available DHA-containing
lyso-PLs, in agreement with observed depletion of total DHA in
developing E- embryos [21], for maintenance of membrane DHA-
containing PLs. This may be particularly distressing to the brain,
which sequesters substantial amounts of DHA during neurodeve-
lopment [38], especially as LPC 22:6 is the preferred transport and
uptake form of DHA across the blood-brain barrier [19, 39]. It is
possible that the decrease in LPC 22:6 during development in the
E embryos represents an impaired ability to provide adequate
DHA to the brain, and that by 96 hpf (the time at which behavior
was assessed) this may adversely affect neurological function. Si-
milarly, as the major storage form of DHA in nervous tissue is
within membrane PE lipids [40,41], lower LPE 22:6 levels in the
E embryos suggests a simultaneous decrease in the brain DHA
reservoir that also could underlie abnormal behavior.
Other changes in the lyso-PL composition of the E embryos
are worthy of comment: for example, LPI 20:4, the only inositol-
containing PL to be signiﬁcantly different between E and Eþ
Fig. 7. H218O incorporation into PCs and lyso-PCs is greater in E than in Eþ embryos. A and C. Ratios of [Mþ2þH]þ/[MþH]þ from H2O-incubated E vs. Eþ embryos
were similar (solid bars; no signiﬁcant differences) in PCs (A) and lyso-PCs (C); ratios comparing label incorporation in H218O-incubated E vs. Eþ embryo (patterned bars)
revealed enhanced labeling in E embryos of DHA-containing PCs, as well as in LPC 16:0 and 22:6, suggesting increased PL remodeling. PC species (means7SEM) were
identiﬁed and conﬁrmed as described in Fig. 4; PC 38:6 (16:0/22:6); PC 40:6 (18:0/22:6); PC 40:8 (18:2/22:6); PC 42:7 (20:3/22:4). All PLs and lyso-PLs showed signiﬁcant
(po0.001) label incorporation in H2O- vs. H218O-incubated embryos within the same diet condition, with the exception of Eþ embryos LPC 22:6 in H2O- vs. H218O-incubated
(no signiﬁcant difference, indicating no signiﬁcant remodeling in Eþ embryos). Asterisks indicate statistical differences between H218O E and Eþ groups (red and blue
patterned bars, respectively). B and D. [Mþ2þH]þ/[MþH]þ in H218O minus [Mþ2þH]þ/[MþH]þ in H2O (mean7SEM) in E vs. Eþ embryos for PCs (B) and lyso-PCs (D).
A–D: Two-way ANOVA with Tukey's (A,C) or Sidak's (B,D) post-test for multiple comparisons (*po0.05, ** po0.01, ***po0.001, ****po0.0001).
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function of ARA is phospholipid-mediated signal transduction. In
the brain, phospholipase A2 (PLA2), which removes ARA from the
sn-2 position of membrane PLs, is activated by glutamatergic,
serotonergic, cholinergic, and dopaminergic signaling, releasing
ARA as a secondary messenger [42,43]. ARA also is the major
substrate for synthesis of bioactive eicosanoids, endogenous sti-
mulators of myriad cellular responses [44], such as inﬂammation,
that act through signal transduction pathways mediated by in-
ositol PLs [45,46].The relevance of altered levels of PI lipids and the
perturbed brain function as well as morphological deformities
observed in E embryos represents, therefore, an area that war-
rants additional research.
It should be noted that not all lyso-PLs were depleted in E
embryos. Levels of LPC 16:0 were higher in the E than in the Eþ
condition throughout development. The increase in LPC 16:0
during development in the E group, along with the reported
concomitant decrease in LPC 22:6 (Fig. 5), supports our hypothesis
that membrane turnover of DHA-containing PLs (especially DHA
38:6, which contains both 16:0 and 22:6 fatty acyl chains) is en-
hanced in E embryos. Hypothetically, if DHA is depleted by lipid
peroxidation, then the saturated lyso-PLs (e.g. LPC 16:0) would be
expected to increase following PLA2 action [47,48].
This evidence agrees with the outcomes of our H218O labeling
experiment, which revealed that E embryos had greater in-
corporation of the H218O label into several DHA-containing PLs
(Fig. 7), as well as LPC 22:6, a required substrate for membrane PC
remodeling. In the E group, H218O incorporation also was ele-
vated signiﬁcantly in LPC 16:0 (Fig. 7C and D), further supporting
our hypothesis that PC 38:6 (and by extension other DHA-con-
taining PLs) is depleted from the membrane PL pool due to in-
creased turnover. In addition, LPC 22:6 label incorporation was notincreased signiﬁcantly in the Eþ embryos (Fig. 7C), indicating that
in the presence of adequate α-tocopherol, the DHA-containing
lyso-PL reserve (with DHA presumably at the sn-2 position for
incorporation into remodeled membrane PLs) remains stable.
While our 24 h incubation time and high H218O label concentra-
tion protocol may reveal only the most gross changes in PL re-
modeling processes due to α-tocopherol deﬁciency, the fact that
we found such selective labeling of DHA-containing PLs, species
that also were decreased in the E condition, makes the outcomes
of this experiment all the more signiﬁcant.
The alterations in both PL and lyso-PL levels and label in-
corporation we observed in the E relative to the Eþ embryos
are, potentially, the result of a depletion of DHA-containing lipids
and an increased requirement for DHA to remodel and repair af-
fected PLs. Hypothetically, with respect to our recent ﬁnding of
increased DHA peroxidation in adult E zebraﬁsh brains, [13]
insufﬁcient α-tocopherol concentrations during development may
allow lipid peroxidation to deplete not only brain DHA-PLs, but
DHA throughout the body, thereby limiting DHA delivery (e.g. via
LPC 22:6) to the brain. We have evidence of increased DHA per-
oxidation in E embryos [21], suggesting that this is the cause of
the selective depletion and enhanced remodeling of DHA-con-
taining lipids reported in the present study. While we did search
our lipidomics data speciﬁcally for oxidized DHA (and other PUFA)
derivatives, the amount of sample material proved to be too small
to allow for accurate identiﬁcation and quantiﬁcation of these
oxidized lipids. Larger sample sizes and more targeted analyses
will be necessary to conﬁrm that greater lipid peroxidation in the
E condition leads to the ensuing depletion and enhanced re-
modeling of DHA-containing PLs that we observed.
In summary, the results of this study show that embryonic α-
tocopherol deﬁciency causes: 1) morphological abnormalities, 2)
M.Q. McDougall et al. / Redox Biology 8 (2016) 165–174 173an impaired locomotor response suggestive of compromised
neurological function, 3) signiﬁcant changes to the PL and lyso-PL
proﬁle of developing zebraﬁsh embryos, and 4) a selective de-
crease in DHA-containing PL and lyso-PL species during the de-
velopmental time-course that matches evidence of their enhanced
turnover in E embryos. Our data demonstrate that critical lipids
are protected by α-tocopherol and suggest that their depletion
may be involved in the mechanism(s) leading to observed beha-
vioral defects and increased mortality.Acknowledgments
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